Key result
Among 775 patients with concurrent heart failure and dementia, 1-year mortality was 24%, and neither dementia type nor heart failure type was associated with increased mortality.
Answers are grounded in this paper and cite their sources.
This editorial emphasizes the critical need for systematic recognition of cognitive impairment in older heart failure patients to optimize tailored care, prevent complications, and facilitate shared decision-making.
This article refers to ‘Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders’†† doi:10.1002/ejhf.222, by P. Cermakova et al., published in this issue on pages 612–619. Heart failure and cognitive impairment are both common conditions in old age. Cognitive impairment is often recognized in conjunction with heart failure, but the reported prevalence has varied from study to study, ranging from 25% to 75%.1. Heart failure and cognitive impairment share several common pathological processes and risk factors, and cause or consequence has been a subject of discussion. Owing to an aging population the prevalence of both is expected to increase in the coming years. In the study published in this journal the authors combined two Swedish registries to study different types of heart failure and their relation to different types of dementia.2 The mean age of participants was 81.8 years. Vascular dementia was the most prevalent type (36%). This was to be expected, as many patients with atherosclerosis are prone to suffer both from heart failure and cognitive impairment caused by dementia of the vascular type. Only 16% of the dementia heart-failure patients were diagnosed with Alzheimer disease. The main type of heart failure was that with preserved ejection fraction, which is more prevalent in those of greater age. No relationship could be demonstrated between type of dementia and type of heart failure. One-year mortality was found to be 24%. Neither dementia nor type of heart failure was associated with increased mortality. Interestingly, of the 55 313 patients included in the heart failure registry only 775 patients (1.4%) were included in the dementia registry. In the literature, the reported prevalence of cognitive impairment in heart failure patients is at least 15-fold higher. The relationship between heart failure and cognitive impairment has been described in many studies. Both conditions share common risk factors such as hypertension, diabetes, and other known cardiovascular risk factors. This has led to two theories: dementia is a direct consequence of heart failure or heart failure and dementia originate from the same pathological processes. Studies have shown a rise in cognitive dysfunction in patients with higher New York Heart Association (NYHA) classification.3, 4 Indirect evidence also favours the theory that cognitive impairment is a consequence of heart failure, as improvement in cerebral blood flow and in cognition has been reported after heart transplantation and after cardiac resynchronization therapy.5, 6 The exact pathophysiological mechanisms that are shared are still unresolved, but hypoperfusion and/or micro-emboli seem to play an important role.7, 8 The present study gives credence to the hypothesis of common pathogenetic mechanisms, demonstrated by the increased association between vascular dementia and heart failure. Coexisting factors also contribute to cognitive impairment, such as depression, medication (especially medication with anti-cholinergic properties), and malnutrition. The coexistence of cognitive impairment, and especially dementia, in heart failure patients leads to a worse prognosis. Studies have shown up to a fivefold increase in mortality in patients with heart failure when cognitive impairment is present.9 This may be ascribed to lower adherence to lifestyle measures and intensive medication regimes, and worse recognition of symptoms, with a consequent higher rate of adverse events such as hospital [re]admission, institutionalization, and mortality (10). Hospitalized heart failure patients with cognitive dysfunction are at higher risk of developing hospital complications such as delirium, malnutrition, and falls, with subsequent consequences for their cognition as well as for their physical functioning. Heart failure combined with cognitive impairment might also lead to an increased overall loss of health-related quality of life. Even though many studies show cognitive impairment to be an important co-morbid condition in heart failure patients, little attention is still paid to systematic recognition of cognitive impairment in this population. According to the European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure (2012) ‘the goals of treatment in patients with established heart failure are to relieve symptoms and signs, prevent hospital admission, and improve survival’.11 Timely recognition of cognitive impairment is important for providing optimal patient care. It may allow adjusting of medication and lifestyle regimes, simplification of dietary restrictions, and better coordination of appointments. This may prevent unnecessary hospital admissions and preserve quality of life. Recognition of cognitive impairment is also important information in the decision-making process regarding pros and cons of cardiological interventions aimed at decreasing symptoms and prolonging life. In elderly patients this survival may not be the most relevant outcome measure. Fried et al.12 showed that almost 80% of elderly patients viewed independent living as their most important treatment outcome—even more important than survival. Treatment decisions should be made in accordance with the patient's personal goals and values, keeping in mind what is personally and medically reasonable.13, 14 The availability of promising new techniques and possibilities, such as implantable cardioverter defibrillator (ICD) devices and (transcatheter) valve implantation offer new possibilities for patients. However, they have also made decision-making for complex and elderly patients even more difficult. To bring about a good decision-making process and prevent unrealistic expectations, it has to be clear, as far as possible, which outcomes will be addressed by a certain intervention. Illness-related outcomes as well as patient relevant outcomes should all be valued in treatment decisions. In the process of shared decision making it is important to acknowledge if a treatment or technical procedure has the potential to stabilize or even improve the patient's physical functioning and independence and hence their perceived quality of life. Within this scope, advanced care planning should also be a subject early on in the decision-making process; for example pre-emptively discussing whether increasing cognitive impairment is grounds for deactivation in the case of ICD implantation. In discussing and explaining different treatment goals, it is of course crucial to know if the patient understands the possibilities offered, and is capable of making informed decisions. This patient appraisal can be easily influenced by cognitive impairment. Recognizing clinical relevant cognitive impairment starts by regarding this condition as an important co-morbidity in heart failure, similar to, for example, renal failure. Clinical signs of cognitive impairment can include the head-turning sign (looking at carers for answers to questions), inability to walk and talk at the same time (‘stops walking while talking’), slowing of movements and thinking, decreases in self-care, and the presence of a family member with a patient that has previously come to the outpatient clinic alone. As mentioned earlier, more regular hospital admissions could also be a sign of cognitive impairment, a result of a lack of adherence to treatment. In patients showing these signs, formal cognitive testing, which requires more time and expertise, should be performed, preferably as part of a comprehensive geriatric assessment.10 Cognitive testing should include all relevant cognitive domains, such as memory, attention, psychomotor speed, and executive functioning (developing and carrying out plans).15 In acutely admitted hospitalized patients in particular, cognitive impairment, as seen in dementia, should be differentiated from delirium, which is an acute and potential reversible medical condition. As part of normal care, periodic screening for cognitive decline in older patients with heart failure could be introduced in the heart failure care service. Specialized heart failure nurses may play a pivotal role in this assessment. Early recognition of cognitive impairment in heart failure patients with adjusted, more tailored, treatment options may lead to a significant quality improvement in heart failure services for elderly patients. Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Festen et al. (2015) conducted an editorial in Heart failure and dementia (n=775). Dementia and heart failure subtypes was evaluated on 1-year mortality. Among 775 patients with concurrent heart failure and dementia, 1-year mortality was 24%, and neither dementia type nor heart failure type was associated with increased mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: